Differences in eicosanoid and cytokine production between injury/hemorrhage and bacteremic shock in the pig

Shock

Volumn 8, Issue 4, 1997, Pages 276-283

  Foëx, Bernard A ^a   Quinn, Jim V ^a   Little, Rod A ^a   Shelly, Máire P ^a   Slotman, Gus J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UMDNJ Robert Wood Johnson Medical School at Camden   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ICOSANOID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BIOSYNTHESIS; BLOOD; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; HEMODYNAMICS; HEMORRHAGIC SHOCK; PATHOPHYSIOLOGY; SEPTIC SHOCK; SWINE; TRAUMATIC SHOCK;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; EICOSANOIDS; FEMALE; HEMODYNAMIC PROCESSES; SHOCK, HEMORRHAGIC; SHOCK, SEPTIC; SHOCK, TRAUMATIC; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031255028     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199710000-00007     Document Type: Article

References (35)

1. Bion J, Strunin L: Multiple organ failure: From basic science to prevention. Br J Anaesth 77:1-2, 1996.
2. Bone RC, Balk RA, Cerra FB, et al: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Crit Care Med 20:864-874, 1992.
3. Goetzl EJ, An S, Smith WL: Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J 9:1051-1058, 1995.
4. Slotman GJ, Quinn JV, Burchard KW, Gann DS: Thromboxane, prostacyclin, and the hemodynamic effects of graded bacteremic shock. Circ Shock 16:395-404, 1985.
5. Camporesi EM, Oda S, Fracica PJ, et al: Eicosanoids and the hemodynamic course of live Escherichia coli-induced sepsis in baboons. Circ Shock 29:229-244, 1989.
6. Slotman GJ, Burchard KW, Williams JJ, D'Arezzo A, Yellin SA: Interaction of prostaglandins, activated complement, and granulocytes in clinical sepsis and hypotension. Surgery 99:744-750, 1986.
7. Rivkind AI, Siegel JH, Guadalupi P, Littleton M: Sequential patterns of eicosanoid, platelet, and neutrophil interactions in the evolution of the fulminant post-traumatic adult respiratory distress syndrome. Ann Surg 210:355-373, 1989.
8. 2-dependent suppression of interleukin alpha (IL-2). J Trauma 27:837-848, 1987.
9. 2 production in severely injured patients. Arch Surg 123:293-299, 1988.
10. Ertel W, Morrison MH, Ayala A, Perrin MM, Chaudry IH: Blockade of prostaglandin production increases cachectin synthesis and prevents depression of macrophage functions after hemorrhagic shock. Ann Surg 213:265-271, 1991.
11. Tracey KJ, Fong Y, Hesse DG, et al: Anticachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664, 1987.
12. Michie HR, Manogue KR, Spriggs DR, et al: Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:1481-1486, 1988.
13. Damas P, Reuter A, Gysen P, Demonty J, Lowry M, Franchimont P: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 17:975-978, 1989.
14. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH: Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol 260:R167-R171, 1991.
15. Stylianos S, Wakabayashi G, Gelfand JA, Harris BH: Experimental hemorrhage and blunt trauma do not increase circulating tumor necrosis factor. J Trauma 31:1063-1067, 1991.
16. Timms RJ: A study of the amygdaloid defence reaction showing the value of Althesin anaesthesia in studies of the function of the forebrain in cats. Pflüger's Arch 391:49-56, 1981.
17. Overman RR, Wang SC: The contributory role of the afferent nervous factor in experimental shock: Sublethal hemorrhage and sciatic nerve stimulation. Am J Physiol 148:289-295, 1947.
18. Rady MY, Kirkman E, Cranley J, Little RA: A comparison of the effects of skeletal muscle injury and somatic afferent nerve stimulation on the response to hemorrhage in anesthetized pigs. J Trauma 35:756-761, 1993.
19. 2 mediates hemodynamic and respiratory dysfunction in graded bacteremia. Surgery 100:214-221, 1986.
20. Woolley DS, Puglisi RN, Quinn JV, Slotman GJ: Platelet activating factor mediates cardiopulmonary dysfunction during graded bacteremic shock. J Trauma 41:291-297, 1996.
21. Matthews JNS, Altman DG, Campbell MJ, Royston P: Analysis of serial measurements in medical research. Br Med J 300:230-235, 1990.
22. Altman DG: Practical Statistics for Medical Research. London U.K.: Chapman and Hall, 1991, pp 426-433.
23. Trunkey DD: Trauma. Sci Am 249:20-27, 1983.
24. Faber JE: Effects of althesin and urethan-chloralose on neurohumoral cardiovascular regulation. Am J Physiol 256:R757-R765, 1989.
25. Cox JE, Done SH, Lees P, Walton JR: Preliminary studies of the actions of alphaxalone and alphadolone in the pig. Vet Rec 97:497-498, 1975.
26. Endo S, Inada K, Yamada Y, et al: Plasma endotoxin and cytokine concentrations in patients with hemorrhagic shock. Crit Care Med 22:949-955, 1994.
27. Foëx BA, Kirkman E, Crawley B: Endotoxin translocation: The cost of hemorrhage and injury induced gut hypoperfusion. Shock 5(Suppl.):A48, 1996.
28. Ferran C, Dy M, Sheehan K, et al: Inter-mouse strain differences in the in vivo anti-CD3 induced cytokine release, clin Exp Immunol 86:537-543, 1991.
29. Fletcher JR, Collins JN, Graves ED, et al: Tumor necrosis factor-induced mortality is reversed with cyclooxygenase inhibition. Ann Surg 217:668-675, 1993.
30. Patel JP, Beck LD, Briglia FA, Hock CE: Beneficial effects of combined thromboxane and leukotriene receptor antagonism in hemorrhagic shock. Crit Care Med 23:231-238, 1995.
31. 2 in septic shock: Species differences. Circ Shock 20:291-297, 1986.
32. Moore FA, Moore EE, Poggetti R, et al: Gut bacterial translocation via the portal vein: A clinical perspective with major torso trauma. J Trauma 31:629-636, 1991.
33. Svoboda P, Kantorova I, Ochmann J: Dynamics of interleukin 1, 2 and 6 and tumor necrosis factor alpha in multiple trauma patients. J Trauma 36:336- 340, 1994.
34. Cruickshank AM, Fraser WD, Burns HJG, van Damme J, Shenkin A: Response of serum interleukin-6 in patients undergoing elective surgery of varying intensity, Clin Sci 79:161-165, 1990.
35. Yellin SA, Garrity FL, Williams JJ, Slotman GJ: Microbial filtrates activate granulocytes without complement or prostaglandins. Circ Shock 19:275-282, 1986.